Lorenil 1 Soft Vaginal Capsule 600mg,Lorenil 1 Capsula Molle Vaginale 600mg,EFFIK ITALIA SpA

£37.08

Antimicrobial and antiseptic effect, except in cases of interaction with cortico.

Antimicrobial and antiseptic effect, except in cases of interaction with cortico.
Lorenil 1 Soft Vaginal Capsule 600mg,Lorenil 1 Capsula Molle Vaginale 600mg,EFFIK ITALIA SpA
£37.08

“ACTIVE ingredients: Fenticonazolo nitrate. Excipients: 200 mg capsules: triglycerides of saturated fatty acids, colloidal silicon dioxide ale anhydrous; shell composition: gelatin, glycerol, titanium d ios, sodium etilidrossibenzoato, sodium propilidrossibenzoato. Capsules from 600 mg: liquid paraffin, white petrolatum, soy lecithin, GE Latin, glycerol, titanium dioxide, sodium etilidrossibenzoato, sodium propilidrossibenzoato.
INDICATIONS: Candidiasis of the mucous membranes of the genital organs (vulvovaginitis, affected, fluor infections).
CONTRAINDICATIONS/EFF.SECONDARY: Hypersensitivity to the active substance or to any of the excipients.
DOSAGE: Administer 200 mg vaginal soft capsules at night before bedtime for 3 days or as determined by the physician. In alterna tive they gave a soft capsule of the vagina from 600 mg in the evening in som the service is unique. If symptoms persist, a second administration may be repeated after three days. Caps ule soft are inserted deep into the vagina to the level of the arches.
STORAGE: This medicine does not require special storage conditions.
WARNINGS: use, especially if it is long-term, products for topical use, it can now give rise to sensitization phenomena. At the time of insertion en dovaginale, a moderate burning sensation may occur, which quickly disappears.
INTERACTIONS: None known.
SIDE EFFECTS: the product is generally well tolerated by the mucous membrane; only in exceptional lm were minor and transient erythematous reactions recorded. If hypersensitivity reactions develop or resistant microorganisms develop, treatment should be discontinued. The product, in c waves, recommended for use, is only poorly absorbed, for which systemic effects can be excluded. PREGNANCY AND BREAST-FEEDING: Although the absorption of the drug, if poor, use during pregnancy and breastfeeding is not recommended, except in special cases, and after a careful assessment of the benefit/risk ratio from the skill of the physician.”

Additional information

Weight 0.1 kg
Producing country

Manufacturer

EFFIK ITALIA SpA

Dosage form

Usage